MedTrace Logo

Laughter Yoga Effect on Cancer Patients' Physiopsychological Symptoms

NCT06654869 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2026-05-18

No results posted yet for this study

Summary

Non-pharmacological interventions that promote positive emotional states and coping may play a critical role in care of cancer patients undergoing chemotherapy. .This study aimed to evaluate the effects of laughter yoga on symptoms, hope, and life engagement levels in cancer patients undergoing chemotherapy. Conducted between January and June 2025 at the chemotherapy unit of Atatürk University Research Hospital in Türkiye, this randomized controlled trial included 55 chemotherapy patients who were randomly assigned to an intervention group (n = 27) receiving 40-minute weekly laughter yoga sessions for four weeks or to a control group (n = 28) receiving routine care. Symptom severity, hope, and life engagement were measured at baseline and after four weeks using the Edmonton Symptom Assessment Scale (ESAS), Herth Hope Scale (HHS), and Life Engagement Scale (LES). Post-intervention analyses revealed statistically significant improvements in the intervention group compared to the control group. Patients who received laughter yoga reported significantly lower symptom severity on the ESAS (p \< 0.05), along with significantly higher levels of hope and life engagement as measured by the HHS and LES, respectively (p \< 0.05).

Conditions

  • Cancer
  • Nurse's Role
  • Quality of Life

Interventions

BEHAVIORAL

lauhgter yoga

include laughter yoga effects on cancer patients' symptom management

Sponsors & Collaborators

  • Ataturk University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-06-30
Completion
2025-08-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06654869 on ClinicalTrials.gov